CalciMedica
CALC | NASDAQ
$1.19
-$0.02 (-1.65%)
At close: Nov 16, 2026, 4:00 PM ET
$1.19
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-1.65%
(1D)No price chart data available for 1D timeframe.
Rating
29.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #818/1021 (Top 80%)
Key Statistics
Market Data
Market Cap $8.22M
1D Range
1.14 1.30
52W Range
1.02 33.70
Valuation (TTM)
PE -0.26
PB 1.95
EV/EBITDA 0.40
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $392.00
Cash Flow
FCF Yield -221.3%
SBC Adj. FCF Yield -248.3%
SBC Impact -12.2%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 23.8% |
65.4%
FCF 3Y | 5Y 4.0% |
1.4%
Returns
ROA -105.7%
ROE -3029.6%
ROIC -164.2%
Financial Health
Net Cash
$13.77M
Current Ratio 4.96
Interest Coverage -14.15
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
CalciMedica, Inc., a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequa...
Sector Healthcare
Industry Biotechnology
Employees 15
IPO Date Jun 14, 2023
Website www.calcimedica.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Hold
Price Target
$392.00
Upside
+32841.18%
Buy (1)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove CALC